healthy mine Kimberly Swanson, senior vice president of consulting and professional services, has published a new article discussing three operational and strategic areas that health plans can focus on to address health equity in 2022.
to read it, Click here.
Lighting Solutions Company, a surgical loupe and lighting company, has officially announced its new line of designer loupes and frames. CEO Tina Saw DDS is very excited about this transition and the introduction of a product line consisting of Prada, Tory Burch, Coach and Michael Kors designer frames.
The company was founded in 2020 by Dr. Saw and Thanh Luu. The first product launched was a wireless magnifying glass. According to the company, the light is the most powerful and lightest wireless light in the dental industry. With all the changes and additions to PPE that dentists have to implement, Light Solutions Company quickly popularized cordless and cordless lights. Light Solutions grew rapidly and became one of the best-selling wireless lighting companies in the United States.
Saw and Luu believe in making lamps that are not only incredibly lightweight and powerful, but also affordable for all dental professionals during the pandemic. “Dental professionals like us were already facing a lot of financial challenges when we opened our dental practice, and we wanted to ease the burden and bring game-changing wireless lighting technology,” Saw said.
Today, Light Solutions is excited to incorporate fashion and technology into its company, while offering customers incredibly affordable prices. “We don’t believe in dental marks. We believe in service and quality, and we do that by employing e-commerce and digital technology,” Luu said.To learn more about Light Solutions Company, please Click here.
Zephyr Artificial Intelligencea health technology company in the field of precision medicine, Has raised $18.5 million in seed funding. Lerner Group Investments and M-Cor Holdings led the round, with participation from Allen Chao, AME Cloud Ventures, BoxGroup, MedStar Health, Roger Ferguson, Steve Oristaglio, Verily and other strategic investors.
According to the press release, the company aims to advance precision medicine drug discovery by ingesting complex, disparate data and applying new machine learning algorithms to derive new insights.
red blood cell partners, an investment and incubation firm that supports, builds and scales technology-leading companies in healthcare and national security, launched last year.
David Morgan, CEO of Zephyr AI, said: “This significant financing will help us expand our reach to include managing additional healthcare datasets, improving advanced machine learning models, and gaining actionable insights for insights into patient care and medicines. Better results in terms of discovery.”
understand more, Click here.
Sema4a company focused on AI-driven clinical data intelligence, published a study with Mount Sinai, using Sema4Network modeling to identify new targets for the treatment of patients with lung adenocarcinoma, the most common form of lung cancer in the United States.
The researchers collected early-stage lung adenocarcinoma tumor samples in a collaborative study. They sequenced the RNA, which was analyzed by Sema4’s gene-gene interaction network based on the sequencing data. This work identifies a gene expression signature that can differentiate between aggressive and non-aggressive tumors and unravel the molecular mechanisms underlying tumor invasion in early-stage lung adenocarcinoma to improve patient diagnosis, prognosis, and treatment.
“This new paper shows how the synergy of computational, in vitro and in vivo technologies can accelerate the drug discovery process,” said Eric Schhadt, founder and CEO of Sema4 and an author on the paper. “By performing a comprehensive network analysis of early-stage lung adenocarcinomas, we were able to identify a gene expression signature that would enable stratification of patients and provide a potential new treatment approach for these patients.”
picture: Arkindo, Getty Images
